Validation of the Distress Thermometer As a Screening Tool for Psychosocial Distress and Resilience in Parkinson's Disease

Overview

Journal Mov Disord Clin Pract

Publisher Wiley

Specialty Neurology

Date 2024 Mar 12

PMID 38468507

Authors

Nils Schnalke

Esther Tekampe

Tim Feige

Anika Frank

Heinz Reichmann

Bjorn Falkenburger

Simone DSouza

Affiliations

Soon will be listed here.

Abstract

Background: Parkinson's disease (PD) is associated with psychosocial distress that affects patients' quality of life. The distress thermometer (DT) is an 11-point visual analogue scale that is used as a screening tool for the assessment of psychosocial distress, originally developed for oncological diseases.

Objectives: To validate the DT for PD and to explore contributing factors.

Methods: The DT scale was administered to 105 people with Parkinson's Disease (PwPD). Along with it, we assessed motor symptoms (Unified Parkinson's Disease Rating Scale part III [UPDRS III], Hoehn and Yahr-stage [H&Y]), non-motor symptoms (Non-motor Symptom Questionnaire [NMSQ]), anxiety and depression (Hospital Anxiety and Depression Scale [HADS], Fear of Progression-Questionnaire Short Form [FOP-Q-SF], Generalized Anxiety Disorder Scale-7 [GAD-7], 9-question Patient Health Questionnaire [PHQ-9]), the feeling of hope (Herth Hope Index [HHI]) and quality of life (Schedule for the Evaluation of Individual Quality of Life [SEIQoL]).

Results: With a cut-off of 4, the DT identified PwPD with distress with a sensitivity of 97% and a specificity of 38%. With this cut-off, the DT will yield false negative results in 1 out of 100 cases. Factor analyses and a random forest regression of the dataset revealed that distress can be predicted by two factors, which we termed "anxiety" and "depression/resilience/motor symptoms".

Conclusion: The DT is an ultra-short and reliable screening tool for distress in PwPD. DT values below 4 rule out distress with a high degree of certainty. Anxiety and depression are important factors in distress but are counterbalanced by the individuals' psychological resilience.

References

Sousa H, Oliveira J, Figueiredo D, Ribeiro O . The clinical utility of the Distress Thermometer in non-oncological contexts: A scoping review. J Clin Nurs. 2021; 30(15-16):2131-2150. DOI: 10.1111/jocn.15698. View

Jin X, Wang L, Liu S, Zhu L, Loprinzi P, Fan X . The Impact of Mind-body Exercises on Motor Function, Depressive Symptoms, and Quality of Life in Parkinson's Disease: A Systematic Review and Meta-analysis. Int J Environ Res Public Health. 2019; 17(1). PMC: 6981975. DOI: 10.3390/ijerph17010031. View

Jacobsen P, Donovan K, Trask P, Fleishman S, Zabora J, Baker F . Screening for psychologic distress in ambulatory cancer patients. Cancer. 2005; 103(7):1494-502. DOI: 10.1002/cncr.20940. View

Donovan K, Grassi L, Deshields T, Corbett C, Riba M . Advancing the science of distress screening and management in cancer care. Epidemiol Psychiatr Sci. 2020; 29:e85. PMC: 7214715. DOI: 10.1017/S2045796019000799. View

Everitt B . Multivariate analysis: the need for data, and other problems. Br J Psychiatry. 1975; 126:237-40. DOI: 10.1192/bjp.126.3.237. View

Mehnert A, Hartung T, Friedrich M, Vehling S, Brahler E, Harter M . One in two cancer patients is significantly distressed: Prevalence and indicators of distress. Psychooncology. 2017; 27(1):75-82. DOI: 10.1002/pon.4464. View

Forsaa E, Larsen J, Wentzel-Larsen T, Herlofson K, Alves G . Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord. 2008; 23(10):1420-7. DOI: 10.1002/mds.22121. View

Hanley J, McNeil B . The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982; 143(1):29-36. DOI: 10.1148/radiology.143.1.7063747. View

Anthoine E, Moret L, Regnault A, Sebille V, Hardouin J . Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures. Health Qual Life Outcomes. 2014; 12:176. PMC: 4275948. DOI: 10.1186/s12955-014-0176-2. View

10.

Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L . Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer. 1994; 30A(1):37-40. DOI: 10.1016/s0959-8049(05)80015-2. View

11.

Levis B, Benedetti A, Thombs B . Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019; 365:l1476. PMC: 6454318. DOI: 10.1136/bmj.l1476. View

12.

Mayer S, Fuchs S, Fink M, Schaffeler N, Zipfel S, Geiser F . Hope and Distress Are Not Associated With the Brain Tumor Stage. Front Psychol. 2021; 12:642345. PMC: 8192812. DOI: 10.3389/fpsyg.2021.642345. View

13.

Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

14.

Donovan K, Grassi L, McGinty H, Jacobsen P . Validation of the distress thermometer worldwide: state of the science. Psychooncology. 2014; 23(3):241-50. DOI: 10.1002/pon.3430. View

15.

Haverman L, van Oers H, Limperg P, Houtzager B, Huisman J, Darlington A . Development and validation of the distress thermometer for parents of a chronically ill child. J Pediatr. 2013; 163(4):1140-6.e2. DOI: 10.1016/j.jpeds.2013.06.011. View

16.

Waldron D, OBoyle C, Kearney M, Moriarty M, Carney D . Quality-of-life measurement in advanced cancer: assessing the individual. J Clin Oncol. 1999; 17(11):3603-11. DOI: 10.1200/JCO.1999.17.11.3603. View

17.

. Distress management. Clinical practice guidelines. J Natl Compr Canc Netw. 2009; 1(3):344-74. DOI: 10.6004/jnccn.2003.0031. View

18.

Bjelland I, Dahl A, Haug T, Neckelmann D . The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002; 52(2):69-77. DOI: 10.1016/s0022-3999(01)00296-3. View

19.

Ribeiro J, Huang X, Fox K, Franklin J . Depression and hopelessness as risk factors for suicide ideation, attempts and death: meta-analysis of longitudinal studies. Br J Psychiatry. 2018; 212(5):279-286. DOI: 10.1192/bjp.2018.27. View

20.

Derollez C, Carriere N, Kyheng M, Dujardin K, Faillon A, Haidon D . Factors that predict a change in quality of life among Parkinson's disease patients participating in a patient education program. Rev Neurol (Paris). 2021; 177(9):1151-1159. DOI: 10.1016/j.neurol.2021.01.020. View